How’s that for clickbait!!! But trust me there’s a payoff. Plus, this is my shortest post ever so it will be painless! You may have seen the news about Eastman Kodak (KODK) getting into the pharma manufacturing business. As a result, the stock has leapt from $2 on Friday to Continue Reading
The Insuretech Tortoise vs. The Insuretech Hare
I know what you’re all thinking. Here comes another version of all the reasons the overhyped insuretech names aren’t going to make it. Not so fast (said the tortoise)! Today, I will make the case for how the seemingly misguided strategy of the hare may be the better path to Continue Reading
Asset Inflation is Always and Everywhere a Monetary Phenomenon
The great Milton Friedman had many famous quotes. Probably the most well known is the one about there being no such thing as a free lunch (not originally his, but he popularized it). But perhaps the most influential, at least for me, was his observation that “inflation is always and Continue Reading
Private Equity, Annuities, and the Future of Cash Flow Underwriting
With the KKR acquisition of Global Atlantic, it has now become table stakes for the large private equity firms to own an annuity platform. Apollo, Blackstone, Carlyle, KKR are all in the game now. The question at hand is how will this change the annuity business? There is the old Continue Reading
Making Lemons Out of Lemonade
So the Lemonade IPO has doubled and I’m not surprised. In fact, I called it. Wait, you say, when did I write that? In a half written post that didn’t get out in time because I didn’t find out until too late that the deal was coming yesterday instead of Continue Reading